Insider Selling: Lantheus Holdings Inc (LNTH) CFO Sells 3,866 Shares of Stock

Lantheus Holdings Inc (NASDAQ:LNTH) CFO John W. Crowley sold 3,866 shares of the business’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $23.52, for a total transaction of $90,928.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Shares of Lantheus Holdings Inc (NASDAQ:LNTH) traded up $0.20 during midday trading on Friday, hitting $22.60. 214,900 shares of the stock traded hands, compared to its average volume of 298,392. Lantheus Holdings Inc has a 52-week low of $7.95 and a 52-week high of $24.10. The firm has a market capitalization of $844.82 and a price-to-earnings ratio of 28.25. The company has a quick ratio of 2.46, a current ratio of 2.96 and a debt-to-equity ratio of -3.41.

Lantheus (NASDAQ:LNTH) last announced its quarterly earnings data on Thursday, November 2nd. The medical equipment provider reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.04. Lantheus had a net margin of 9.59% and a negative return on equity of 46.45%. The firm had revenue of $79.94 million for the quarter, compared to analyst estimates of $77.18 million. During the same quarter in the prior year, the business earned $0.15 earnings per share. The business’s quarterly revenue was up 9.4% compared to the same quarter last year. sell-side analysts forecast that Lantheus Holdings Inc will post 1.05 earnings per share for the current fiscal year.

Several equities analysts recently issued reports on LNTH shares. Credit Suisse Group boosted their target price on shares of Lantheus from $19.00 to $23.00 and gave the company a “neutral” rating in a report on Friday, November 3rd. Jefferies Group reiterated a “buy” rating and set a $22.00 price objective on shares of Lantheus in a report on Thursday, October 12th. Zacks Investment Research upgraded shares of Lantheus from a “hold” rating to a “strong-buy” rating and set a $26.00 price objective on the stock in a report on Tuesday, November 7th. Wells Fargo & Co upgraded shares of Lantheus from a “market perform” rating to an “outperform” rating in a report on Thursday, November 2nd. Finally, BidaskClub lowered shares of Lantheus from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 5th. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $24.25.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Schwab Charles Investment Management Inc. bought a new stake in shares of Lantheus during the second quarter worth about $770,000. First Trust Advisors LP increased its position in shares of Lantheus by 24.8% during the second quarter. First Trust Advisors LP now owns 23,468 shares of the medical equipment provider’s stock worth $414,000 after acquiring an additional 4,669 shares in the last quarter. Rhumbline Advisers bought a new stake in shares of Lantheus during the second quarter worth about $903,000. Bank of New York Mellon Corp increased its position in shares of Lantheus by 434.6% during the second quarter. Bank of New York Mellon Corp now owns 366,048 shares of the medical equipment provider’s stock worth $6,460,000 after acquiring an additional 297,575 shares in the last quarter. Finally, Legal & General Group Plc bought a new stake in shares of Lantheus during the second quarter worth about $908,000. Hedge funds and other institutional investors own 91.91% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Insider Selling: Lantheus Holdings Inc (LNTH) CFO Sells 3,866 Shares of Stock” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international copyright and trademark laws. The correct version of this report can be viewed at https://www.tickerreport.com/banking-finance/3145980/insider-selling-lantheus-holdings-inc-lnth-cfo-sells-3866-shares-of-stock.html.

Lantheus Company Profile

Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.

Insider Buying and Selling by Quarter for Lantheus (NASDAQ:LNTH)

Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.